ライフサイエンスコーパス: antemortem

1 opsy specimens and nasal brushings collected antemortem.

2 on intracardiac thrombus has been evaluated antemortem.

3 ime and a high rate of nosocomial infections antemortem.

4 All patients were diagnosed antemortem.

5 authors identified 54 subjects who underwent antemortem (1)H MR spectroscopy and were clinically heal

6 Antemortem (1)H MR spectroscopy metabolite changes corre

7 = 41, 16 females and 25 males) who underwent antemortem (1)H-MRS of the posterior cingulate gyrus at

8 ears), all of whom were reported to have had antemortem acute chest pain, were imaged with postmortem

9 ibody assays for autoimmunity were performed antemortem after her islet transplantations to test in v

10 ation on the 120 patients who were diagnosed antemortem and agreed to participate in this study.

11 further support the use of RAMALTs collected antemortem as an adjunct to testing of tonsil biopsy spe

12 Postmortem specimens from antemortem assessed and diagnosed elderly patients with

13 tly in the dorsolateral prefrontal cortex of antemortem-assessed and neuropathologically characterize

14 Patients had not been given standardised antemortem assessments.

15 29 of these 34 cases were diagnosed as FTLD antemortem based on the sum of clinical, neuropsychologi

16 The search for antemortem biomarkers is intense and has focused on cere

17 Identifying antemortem biomarkers of LBD stage may provide important

18 btained from three HIV-infected subjects and antemortem blood samples obtained from one of these subj

19 mononuclear cells obtained 21 and 22 months antemortem, but was not present in samples obtained 4 an

20 To test the hypotheses that (1) antemortem cerebrospinal fluid (CSF) tau levels correlat

21 MBIs were strongly associated with the last antemortem CF score; this was significantly mediated by

22 udy describing a lack of correlation between antemortem clinical and laboratory findings and postmort

23 of this article is to study the accuracy of antemortem clinical diagnoses of frontotemporal lobar de

24 tional aspect of medical autopsy (confirming antemortem clinical diagnoses).

25 history of methamphetamine use, considerable antemortem cognitive impairment and abundant astrogliosi

26 ted with milder AD pathology and less severe antemortem cognitive impairment compared to APOEepsilon3

27 The antemortem consensus diagnosis of FTLD was moderately se

28 Materials and Methods After obtaining antemortem consent and institutional review board approv

29 Antemortem consent was obtained from all study participa

30 For a test cohort, antemortem CSF proteins from 34 AD and 34 non-AD patient

31 proteinopathy (n = 49), or AD (n = 26) with antemortem CSF.

32 ed in peripheral colonization as detected by antemortem culture of feces and postmortem (320 days pos

33 re seen in the lung tissue of patients whose antemortem cultures were negative for mycobacteria.

34 hose of 18 patients with CF who had negative antemortem cultures.

35 Antemortem CXR were classified by three B readers using

36 e of PCR amplification of oral swabs for the antemortem detection of Pneumocystis in 12 rat groups fr

37 Based on antemortem diagnoses, demented and nondemented subjects

38 In those with incorrect antemortem diagnoses, three were thought to have Alzheim

39 aerophobia was significantly associated with antemortem diagnosis (odds ratio, 11.0 [95% CI, 1.05 to

40 In contrast, among those with an antemortem diagnosis of dementia, NFTs had the strongest

41 e likely to lead to novel strategies for the antemortem diagnosis of LB disorders as well as to insig

42 All cases of chronic blast exposure had an antemortem diagnosis of post traumatic stress disorder.

43 A in urine points to its potential value for antemortem diagnosis of prion diseases.

44 The antemortem diagnosis of rabies in humans employs techniq

45 the unique manifestations of FTLD, accurate antemortem diagnosis was feasible.

46 To investigate specific methods of antemortem diagnosis, the antibody responses of infected

47 ting point for future efforts to generate an antemortem diagnostic for AD.

48 LDL and LDL particles can be adapted into an antemortem diagnostic test for prions in the blood of hu

49 amination of this type of tissue as a viable antemortem diagnostic test.

50 Antemortem ECGs were available for 5 SADS probands, 1 of

51 Antemortem electrodiagnostics and radiologic imaging ind

52 Thus, antemortem examination with the CDV FAT on external epit

53 f devices obtained through postmortem versus antemortem explantation or whether explantation was due

54 Antemortem findings were then compared to results from a

55 specimens and nasal brush samples collected antemortem from farmed white-tailed deer (n= 409).

56 ociation of micro brain infarcts (MBIs) with antemortem global cognitive function (CF), and whether b

57 ease spectrum pathological diagnosis who had antemortem head MRI scans between Jan 1, 1999, and Dec 3

58 er in recipients whose DCD donors were given antemortem heparin (P = 0.62).

59 location of withdrawal and administration of antemortem heparin, are thought to play important roles

60 e care unit or operating theater) and use of antemortem heparin.

61 Antemortem histopathology suggested disseminated Pythium

62 ossible for physicians to make the diagnosis antemortem in the time available, despite appropriate in

63 Analysis of antemortem infection dynamics demonstrated that the subc

64 able alternative to DBD transplantation, and antemortem interventions including heparinization may be

65 c mouse model and postmortem ventricular and antemortem lumbar CSF from AD patients.

66 Occipital hypometabolism is a potential antemortem marker to distinguish DLB versus AD.

67 Seeking antemortem markers to distinguish Dementia with Lewy bod

68 n brain tissue were significantly related to antemortem measures of global cognitive function, memory

69 med 93% of all 336 diagnoses identified from antemortem medical records, and medical autopsy confirme

70 in fatal cases of pneumonia and can confirm antemortem microbiological diagnoses.

71 We studied 46 individuals who had both antemortem MRI and an autopsy.

72 = 5), converging evidence was obtained using antemortem neuroimaging measures of gray and white matte

73 clinical symptoms and degeneration on serial antemortem neuroimaging, directly correlated with diseas

74 yndrome before their death and related their antemortem neuropsychological performance to postmortem

75 In cases of sudden unexplained death (antemortem or postmortem analysis of the deceased not pe

76 re diffuse Lewy body disease [DLBD]) who had antemortem position emission tomography imaging and auto

77 Antemortem prediction of CBD will remain challenging unt

78 Data on antemortem risk factors were available for 93 of these p

79 PrP(CWD)in rectal biopsy specimens and other antemortem samples and, with further research to identif

80 r large-scale and rapid automated testing of antemortem samples for CWD.

81 homogenate and lung lavage fluid, as well as antemortem samples, such as serum.

82 velopment of sensitive diagnostic assays and antemortem sampling techniques crucial for the mitigatio

83 velopment of sensitive diagnostic assays and antemortem sampling techniques crucial for the mitigatio

84 ntification of anti-P. carinii antibodies in antemortem serum samples is a sufficiently sensitive met

85 8 patients with cystic fibrosis (CF) who had antemortem sputum cultures positive for nontuberculous m

86 ria for AD but show no synapse loss or overt antemortem symptoms of dementia.

87 acenta for PrP-res could be the basis for an antemortem test for sheep scrapie, and show that PrP-res

88 -QuIC would be comparable to IHC analysis in antemortem tissues and would correlate with both the gen

89 Multimodal imaging that was obtained antemortem was matched with ex vivo and high-resolution

90 ain tissue collected from subjects diagnosed antemortem with either no cognitive impairment, MCI, or